About Pricing FAQs Providers Trials Blog

Login Get started

Finding studies

Your health journey, clearly organized.

Questions? feedback@clareohealth.com

Product

How it works
Pricing
For Providers
Trials

Company

About
Blog
FAQ

Legal

Privacy Policy
Terms of Service

© 2026 Clareo Health. All rights reserved.

Clareo Health | Clinical Trials in Ohio | 28,693 Studies Near You

Clinical TrialsOhio

Clinical Trials in Ohio

Discover 28,693 clinical trials near Ohio. Find research studies in your area.

Browse by condition:

Breast Cancer Lung Cancer Prostate Cancer Colorectal Cancer Melanoma Leukemia Lymphoma Pancreatic Cancer

Order

Status

RecruitingNot yet recruitingActive, not recruitingEnrolling by invitationCompletedTerminated

Phase

Early phase 1Phase 1Phase 1–2Phase 2Phase 2–3Phase 3Phase 4No phase

Who can join

Healthy volunteers too

Showing 2021-2040 of 28,693 trials

CompletedCB-839 With Everolimus vs. Placebo With Everolimus in Participants With Renal Cell Carcinoma (RCC)The primary objective of this study is to compare the progression-free survival (PFS) of participants treated with telaglenastat and everolimus versus placebo and everolimus for…NCT03163667·Tucson, Arizona and 37 others

Find Trials by Condition in Ohio

Breast Cancerin Ohio Lung Cancerin Ohio Prostate Cancerin Ohio Colorectal Cancerin Ohio Melanomain Ohio Leukemiain Ohio Lymphomain Ohio Pancreatic Cancerin Ohio Ovarian Cancerin Ohio Brain Cancerin Ohio Diabetesin Ohio

Data from ClinicalTrials.govTerms

CompletedRandomized, Controlled Multicenter Trial of Vacuum Assisted Closure Therapy™ in Diabetic Foot UlcersTo determine if topical negative pressure therapy delivered by the V.A.C.® device is clinically efficacious and cost effective in the treatment of diabetic foot ulcers.NCT00432965·Phoenix, Arizona and 24 others

Active not recruitingVenetoclax Plus R-ICE Chemotherapy for Relapsed/Refractory Diffuse Large B-Cell LymphomaThe purpose of this study is to determine the correct dose and safety of adding a new cancer drug, venetoclax, to a standard combination of chemotherapy drugs as a second…NCT03064867·St Louis, Missouri and 2 others

TerminatedTrial of Andexanet in Patients Receiving an Oral FXa Inhibitor Who Require Urgent SurgeryProspective, open-label clinical trial to evaluate the efficacy and safety of andexanet alfa patients who require urgent surgery that have been anticoagulated with the FXa…NCT04233073·Phoenix, Arizona and 55 others

CompletedExercise for Adults With Limited MobilityThe purpose of this study is to evaluate the effectiveness of a structured and progressive task-oriented, community based exercise program for older adults who have limitations in…NCT05266573·Youngstown, Ohio

CompletedDilated Versus Non-Dilated Wavefront Corrections for Patients With Down SyndromeIndividuals with Down syndrome (DS) live with visual deficits due, in part, to elevated levels of higher-order optical aberrations (HOA).NCT05059041·Columbus, Ohio and 1 other

TerminatedBuspirone as a Potential Treatment for Recurrent Central ApneaThe purpose of this study is to determine whether buspirone compared to acetazolamide and to placebo will reduce the number and/or severity of breathing pauses during sleep that…NCT00746954·Cleveland, Ohio

CompletedClinician Ability to Predict the Presence of Nosocomial Pneumonia Based on Bronchoscopic FindingsThis study aims to determine whether interpretations of bronchoscopic results enable physicians to successfully predict the presence of pneumonia in traumatically injured patients.NCT01904305·Cincinnati, Ohio

CompletedDose Ranging Study of Lunsekimig Compared With Placebo-control in Adult Participants With Moderate-to-severe AsthmaThis is a Phase 2b, global, multicenter, randomized, double-blind, placebo-controlled, parallel group, dose ranging study to assess the efficacy, safety, and tolerability of…NCT06102005·Scottsdale, Arizona and 155 others

RecruitingCurcumin & Astaxanthin for Lowering Triglyceride Readings and InflammationTwo dietary supplements are each being compared to a placebo for the ability to help maintain triglycerides in the normal range.NCT07063056·Dublin, Ohio

CompletedA 26-week Extension of the ZRHR-ERS-09-US Study Evaluating Biological and Functional Changes in Healthy Smokers After Switching to THS 2.2The objective of the ZRHR-ERS-09-EXT-US study is to further assess the effect of the Tobacco Heating System 2.2 (THS 2.2), a candidate Modified Risk Tobacco Product, compared to…NCT02649556·Tempe, Arizona and 18 others

CompletedAGEN1884, an Anti-CTLA-4 Human Monoclonal Antibody in Participants With Advanced or Refractory Cancer and Who Have Progressed With PD-1/PD-L1 Inhibitor as Their Most Recent TherapyThis is an open-label, Phase 1/2, multicenter study to evaluate the safety, pharmacokinetics, and pharmacodynamics of an anti-cytotoxic T lymphocyte-associated protein-4 (CTLA-4)…NCT02694822·Duarte, California and 10 others

CompletedShave Margins vs. Standard Partial Mastectomy in Breast Cancer PatientsBreast cancer is the most common malignancy affecting women in the US.NCT02772731·Loma Linda, California and 8 others

Active not recruitingZanubrutinib in Combination With R-PolaCHP (ZaR-PolaCHP) for Newly Diagnosed Diffuse Large B-Cell LymphomaThis phase Ib trial seeks to find out the best dose and possible side effects and/or benefits of zanubrutinib in combination with the R-PolaCHP in treating patients with newly…NCT04850495·Cleveland, Ohio and 2 others

RecruitingNovel Tracer Methods to Evaluate Muscle Protein Metabolism in CirrhosisTo determine the rate and mechanisms of skeletal muscle protein synthesis and breakdown in cirrhotic patients by using multiple tracers and single muscle biopsies.NCT03225677·Cleveland, Ohio

CompletedEdoxaban in Peripheral Arterial DiseaseThis study is a randomized, open-label, blinded endpoint, parallel-group, active-control, multi-center, proof-of-concept study in subjects with Peripheral Arterial Disease (PAD)…NCT01802775·Birmingham, Alabama and 41 others

CompletedA Study of INCB050465 in Relapsed or Refractory Follicular LymphomaThe purpose of this study is to assess the objective response rate of parsaclisib treatment in participants with relapsed or refractory follicular lymphoma.NCT03126019·Phoenix, Arizona and 82 others

TerminatedStudy of Heart Failure Hospitalizations After Aquapheresis Therapy Compared to Intravenous (IV) Diuretic TreatmentThe purpose of the research is to determine if patients have fewer Heart Failure (HF) events after receiving Aquapheresis (AQ) therapy compared to intravenous (IV) diuretics up to…NCT01474200·Huntsville, Alabama and 37 others

CompletedDose Comparisons of Leucine-Metformin Combinations on Blood Glucose Levels In Type 2 Diabetic PatientsThe goal of this study is to demonstrate that leucine in combination with a low does of metformin can serve as an adjunct to diet and exercise to improve blood glucose levels in…NCT02151461·Chino, California and 8 others

CompletedObservational Study to Evaluate, Under Real-world Practice Conditions, the Safety and Effectiveness of Regorafenib in Patients Diagnosed With Unresectable Hepatocellular Carcinoma (uHCC)Observational study to evaluate, under real-world practice conditions, the safety and effectiveness of regorafenib in patients diagnosed with unresectable hepatocellular carcinoma…NCT03289273·Gilbert, Arizona and 36 others

PreviousPage 102 of 1435Next

Heart Diseasein Ohio